Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer.

作者: TOMONORI KATO , HIROYOSHI SUZUKI , AKIRA KOMIYA , TAKASHI IMAMOTO , YUKIO NAYA

DOI: 10.1111/J.1442-2042.2006.01440.X

关键词:

摘要: Aim:  The clinical significance of the urinary white blood cell (U-WBC) count and serum C-reactive protein (CRP) level was evaluated in an effort to improve efficiency prostate biopsies. Methods:  We enrolled 228 consecutive patients with prostate-specific antigen (PSA) ranging from 3.0 20.0 ng/mL, normal digital rectal examination findings, who underwent biopsies between January 2001 August 2004. Of these, 157 had histologically confirmed benign prostatic disease remaining 71 cancer. Patients a pretreatment U-WBC ≤3 or >3/high power field were defined as non-pyuria pyuria, respectively. also separated into two groups based on CRP prior biopsy. Several factors compared among these subgroups. Results:  Inflammation detected at rates 58.1% 34.1% pyuria groups, respectively (P = 0.0014). cancer detection significantly lower than group 0.0384). did not differ according levels biopsy. Conclusion:  appears be reliable indicator minute inflammation. PSA elevated asymptomatic prostatitis. Counting is simple, convenient non-invasive method that should valuable part routine urological examinations.

参考文章(18)
MICHAEL K. BRAWER, CAROL D. CHELI, IRENE E. NEAMAN, JOAN GOLDBLATT, CAROL SMITH, MORTON K. SCHWARTZ, DEBRA J. BRUZEK, DEBORAH L. MORRIS, LORI J. SOKOLL, DANIEL W. CHAN, KWOK K. YEUNG, ALAN W. PARTIN, W. JEFFREY ALLARD, COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER The Journal of Urology. ,vol. 163, pp. 1476- 1480 ,(2000) , 10.1016/S0022-5347(05)67646-X
J. N. Krieger, NIH Consensus Definition and Classification of Prostatitis JAMA: The Journal of the American Medical Association. ,vol. 282, pp. 236- 237 ,(1999) , 10.1001/JAMA.282.3.236
J. Morote, M. Lopez, G. Encabo, I.M. de Torres, Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. European Urology. ,vol. 37, pp. 537- 540 ,(2000) , 10.1159/000020190
Jacques Irani, Pierre Levillain, Jean-Michel Goujon, Didier Bon, Bertrand Dore, Jacques Aubert, Inflammation in Benign Prostatic Hyperplasia: Correlation With Prostate Specific Antigen Value The Journal of Urology. ,vol. 157, pp. 1301- 1303 ,(1997) , 10.1016/S0022-5347(01)64957-7
William J Catalona, Paula C Southwick, Kevin M Slawin, Alan W Partin, Michael K Brawer, Robert C Flanigan, Anup Patel, Jerome P Richie, Patrick C Walsh, Peter T Scardino, Paul H Lange, Gail H Gasior, Kathleen G Loveland, Kurtis R Bray, Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology. ,vol. 56, pp. 255- 260 ,(2000) , 10.1016/S0090-4295(00)00637-3
Masahiko Inahara, Hiroyoshi Suzuki, Hiroshi Nakamachi, Naoto Kamiya, Masaki Shimbo, Akira Komiya, Takeshi Ueda, Tomohiko Ichikawa, Koichiro Akakura, Haruo Ito, Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer. International Urology and Nephrology. ,vol. 36, pp. 175- 180 ,(2004) , 10.1023/B:UROL.0000034664.39784.33
M.C. Wang, L.A. Valenzuela, G.P. Murphy, T.M. Chu, PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN The Journal of Urology. ,vol. 167, pp. 960- 964 ,(2002) , 10.1016/S0022-5347(02)80311-1
Igor Stancik, Werner Lüftenegger, Martin Klimpfinger, Matthias M. Müller, Wolfgang Hoeltl, Effect of NIH-IV Prostatitis on Free and Free-to-total PSA European Urology. ,vol. 46, pp. 760- 764 ,(2004) , 10.1016/J.EURURO.2004.08.003